← Open Payments lookup

JAMES PRATTY: Open Payments

NPI 1528049608 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$78,299 in 171 payments from 13 companies in 2025. Trend: 2023 $100,910 · 2024 $60,983 · 2025 $78,299

Speaker / faculty: $58,385Travel & lodging: $10,656Consulting: $4,761Food & beverage: $4,386Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)42$27,105
Vanda Pharmaceuticals Inc.43$26,239
ABBVIE INC.30$13,164
Teva Pharmaceuticals USA, Inc.17$10,822
Alkermes, Inc.12$303
Luye Pharma (USA) Ltd.9$227
Janssen Pharmaceuticals, Inc10$204
E.R. Squibb & Sons, L.L.C.3$104
Otsuka America Pharmaceutical, Inc.1$32
Lundbeck LLC1$32

Products named: CAPLYTA, FANAPT, VRAYLAR, AUSTEDO XR, ARISTADA, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, COBENFY.

Industry payments across CA — which companies pay providers there.